Page 8 - Les meilleurs oncologues en en Turquie - TOP-158 des médecins

Éducation et spécialisation

• 2006 : Faculté de médecine de l'Université de Kocaeli
• 2014 : Faculté de médecine de l'Université d'Akdeniz, Médecine interne
• 2018 : Faculté de médecine de l'Université d'Akdeniz, Oncologie médicale

Expérience

• 2006 - 2008 : Hôpital du district de Konya Derebucak
• 2009 - 2015 : Hôpital universitaire d'Akdeniz
• 2015 : Hôpital d'État d'Antalya Kaş
• 2015 - 2016 : Faculté de médecine de l'Université d'İnönü
• 2016 - 2021 : Hôpital universitaire d'Akdeniz
• 2021 - 2023 : Hôpital de formation et de recherche d'Antalya

Domaines d'intérêt médicaux

• Chirurgie mini-invasive thoracoscopique et robotique

• Cancers du poumon

• Chirurgie de la trachée

• Transplantation pulmonaire

• Biopsie pulmonaire • Pneumothorax (poumon affaissé)

• Chirurgie diaphragmatique • Chirurgie des maladies pleurales

• Chirurgie thoracique pédiatrique

Éducation

• Université d'Istanbul, Faculté de médecine d'Istanbul

• Lycée Galatasaray d'Istanbul

• Enseignement primaire Ankara, Samsun, Izmir

Éducation et résidence

2001 à 2007 : Formation médicale, École de médecine de Meram, Université de Selçuk

2009 à 2014 : Formation en résidence, École de médecine, Université Atatürk

Expérience

2009 à 2014 : Résidence, Département d'orthopédie et de traumatologie, Faculté de médecine, Université Atatürk

2015 à 2016 : Conscription, Hôpital d'État de Kozluk, Batman

2016 : Oncologie orthopédique, Formations expérientielles, Hôpital Ibn-I Sina, Université d'Ankara

2017 : Oncologie orthopédique, Formations d'expérience, École de médecine Acıbadem

2021 : Formation en oncologie orthopédique, École de médecine d'Acıbadem

Adhésions professionnelles

-Association des tumeurs des os et des tissus mous

-Association d'arthroplastie de la hanche et du genou

-Service de chirurgie du pied et de la cheville

-Association de reconstruction des extrémités et de développement des méthodes Ilizarov

-Fédération de la Société Turque d'Orthopédie et de Traumatologie (TOTBID)

Areas of Interests

• Breast cancer
• Lung cancer
• Colorectal cancers
• Gynecological and urogenital cancers
• Molecular Oncology

Education:

• Kızıltepe Anatolian High School 2001
• Dicle University Faculty of Medicine 2007
• Istanbul Medeniyet University Göztepe Training and Research Hospital 2014
• Kartal City Hospital 2021
• Associate Professor of Medical Oncology 2023

Experience:

• Liv Hospital Ulus
• Adıyaman University Training and Research Hospital
• Istanbul Umraniye Training and Research Hospital
• Istanbul Umraniye Training and Research Hospital

Research:

• Phase II, Randomized, Open-Label, Multicenter Study to Comparatively Evaluate the Efficacy and Safety of GDC-9545 and Physician-Preferred Endocrine Monotherapy in Previously Treated, Estrogen Receptor Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer Patients, Other ( International), Dr. Murat Ayhan
• Phase III, Randomized, Evaluating the Efficacy and Safety of Palbociclib and Fulvestrant with Gdc-0077 Compared with Placebo in Patients with Pik3ca-Mutant, Hormone Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer. Double Blind, Placebo Controlled Study, Other (International), Dr. Murat Ayhan
• Randomized, Multicenter, Phase Ib/III Study Evaluating the Pharmacokinetics, Efficacy, and Safety of Subcutaneous Atezolizumab Compared to Intravenous Atezolizumab in Patients with Previously Treated Locally Advanced or Metastatic Non-Small Cell Lung Cancer, Other (International) Dr. Murat Ayhan
• Randomized, Controlled, Multicenter, Open-Label Study Including Observation Follow-Up for PSMA-PET-Negative Patients, Investigating the Efficacy and Safety of Addition of Apalutamide to Radiotherapy and LHRH Agonist in PSMA-PET-Positive High-Risk Hormone-Sensitive Prostate Cancer Patients, Other (International) Dr. Murat Ayhan
• Biomarker Study to Identify Patients with Advanced Stage Urothelial Cancer and Fibroblast Growth Factor Receptor Gene Aberrations-42756493BLC0002, Other (International), Dr. Murat Ayhan
• Publications:
• Ayhan M, Turan N, Köstek O, et all. Does the efficacy of regorafenib differ in chemotherapy refractory metastatic colorectal cancer patients who had mucinous pathology compared to those who had non-mucinous pathology? Curr Probl Cancer. 2021 Jun;45(3):100670. doi: 10.1016/j.currproblcancer.2020.100670.
• Ayhan M, Odabas H, Turan N, et all. Factors affecting the mortality rate of patients with cancer hospitalized with COVID-19: a single center's experience. J Chemother. 2021 Nov;33(7):499-508. doi: 10.1080/1120009X.2021.1923153.
• Ayhan M, Laçin Ş, Özyükseler DT, et all. Does systemic anti-tumor therapy increase COVID-19 risk in patients with cancer? J Oncol Pharm Pract. 2021 Sep;27(6):1461-1467. doi: 10.1177/10781552211015762.
• Ayhan M, Abamor E, Coban Kokten S, et al. Value of FDG PET/CT in Predicting Pathologic Complete Response After Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer. EJMI 2022;6(2):165–175.
• Ayhan M, Terzioglu K. Experience With Rapid Drug Desensitization With Chemotherapeutics; A SingleCentre Retrospective Study. EJMI 2021;5(3):380–387.
• Doğan A, AYHAN M. Survival analysis of patients with triple-negative breast cancer: a single-center experience. Journal of Oncological Sciences, 8(2), 94-99., Doi: 10.37047/jos.2022-89749
• Terzioğlu K, Ayhan M. Comparative Assessment of Platinum Salts and Taxane Group Hypersensitivity Reactions, The Role of Skin Tests in Diagnosis? J Oncol Pharm Pract. 2021 Nov 30:10781552211050084. doi: 10.1177/10781552211050084.
• Tacar SY, Selcukbiricik F, Yilmaz M, Erturk K, Murat Sarici A, Gulturk I, Ayhan M, Tural D. Nivolumab for metastatic uveal melanoma: a multicenter, retrospective study. Melanoma Res. 2021 Oct 1;31(5):449-455. doi: 10.1097/CMR.0000000000000744.
• Özyurt E, Özçelik S, Sürmeli H, Çelik M, Ayhan M, Özçelik M. Side effects of immune-checkpoint inhibitors: Can multiple side effects be seen in a patient? J Oncol Pharm Pract. 2022 Mar;28(2):462-465. doi: 10.1177/10781552211038136.
• Dülgar Ö, Öven BB, Atcı MM, Arıkan R, Ay S, Ayhan M, Selvi O, Ozyukseler DT, Bayram E, Özcan E, Yasin Aİ, Gümüş M. Is the benefit of using adjuvant capecitabine in patients with residual triple-negative breast cancer related to pathological response to neoadjuvant chemotherapy? Expert Rev Anticancer Ther. 2022 Jul;22(7):773-780. doi: 10.1080/14737140.2022.2076670.
• Hizal M, Bilgin B, Paksoy N, Ayhan M, et all. The real-life efficacy and safety of osimertinib in pretreated advanced non-small cell lung cancer patients with T790M mutation: a Turkish Oncology Group Study. J Cancer Res Clin Oncol. 2022 Jun;148(6):1501-1508. doi: 10.1007/s00432-021-03748-7.
• Volume I, Kucukarda A, Atcı MM, Ayhan M, et all. Efficacy and safety of trastuzumab emtansine in older patients with HER2-positive advanced breast cancer: a real-world study. Tumori. 2022 Feb;108(1):19-25. doi: 10.1177/03008916211037739.
• Dogan I, Ayhan M, Gurbuz M, et all. The frequency and prognostic significance of ABO/Rh blood groups in male breast cancer patients: A multicenter study. Medicine (Baltimore). 2022 Sep 2;101(35):e30147. doi: 10.1097/MD.0000000000030147.
• Ozcelik M, Oyman A, Cil I, Duzgun O, Ozkan OF, Ayhan M. Cytoreductive Surgery versus Systemic Chemotherapy alone in Isolated Peritoneal Carcinomatosis of Colorectal Origin. J Coll Physicians Surg Pak. 2021 Nov;31(11):1308-1313. doi: 10.29271/jcpsp.2021.11.1308.
• Başoğlu T, Sakin A, Erol C, Ayhan M, et all. Real life experienceof patients with locally advanced gastric and gastroesophageal junction adenocarcinoma treated with neoadjuvant chemotherapy: a Turkish oncology group study. J Chemother. 2022 May 17:1-8. doi: 10.1080/1120009X.2022.2073159.
• Özdemir Ö, Zengel B, Yildiz Y, Ayhan M, et all. The effectiveness and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early-stage human epidermal growth factor receptor 2-positive breast cancer: Turkish Oncology Group study. Anticancer Drugs. 2022 Aug 1;33(7):663-670. doi: 10.1097/CAD.0000000000001310.
• Hizal M, Bilgin B, Paksoy N, Ayhan M, et all. The percentage of ALK-positive cells and the efficacy of first-line alectinib in advanced non-small cell lung cancer: is it a novel factor for stratification? (Turkish Oncology Group Study). J Cancer Res Clin Oncol. 2022 Sep 1. doi: 10.1007/s00432-022-04252-2.
• Hizal M, Bilgin B, Paksoy N, Ayhan M, et all. Real-world data on efficacy and safety of first-line alectinib treatment in advanced-stage, ALK-positive non-small-cell lung cancer patients: a Turkish Oncology Group study. Future Oncol. 2022 Jul;18(23):2573-2582. doi: 10.2217/fon-2022-0083.
• Topcu A, Atci MM, Secmeler S, Besiroglu M, Ayhan M, Ozkan M, Bozkurt O, Urakci Z, Ay S, Geredeli C, Yasin AI, Turk HM. Efficacy of trastuzumab and potential risk factors on survival in patients with HER2-positive metastatic gastric cancer. Future Oncol. 2021 Nov;17(31):4157-4169. doi: 10.2217/fon-2021-0398.
• Bilgin B, Sendur MAN, Yucel S, Ayhan M, et all. Real-life comparison of the afatinib and first-generation tyrosine kinase inhibitors in nonsmall cell lung cancer harboring EGFR exon 19 deletion: a Turk Oncology Group (TOG) study. J Cancer Res Clin Oncol. 2021 Jul;147(7):2145-2152. doi: 10.1007/s00432-020-03501-6.
• Atci MM, Akagunduz B, Demir M, Arikan R, Ay S, Ozer M, Ayhan M, Cil I, Demir N, Ozyurt N, Karakaya G, Cevik GT, Onder AH, Selvi O, Sakin A. The impact of adjuvant oxaliplatin and tumor sidedness on the overall survival of stage IIB colon cancer patients: a multicentre study. J Chemother. 2023 Feb;35(1):19-28. doi: 10.1080/1120009X.2022.2040770.
• Tataroglu Ozyukseler D, Ay S, Turan M, Alkan G, Ayhan M, Surmeli H, et al. The Systemic Inflammation Response Index as a Prognostic Marker in Advanced Pancreatic Cancer. EJMI 2022;6(3):367–373.
• Yıldız F, Ayhan M, Demir H, et all. Comparing the efficacy of cabazitaxel in secondline and third-Line treatment of metastatic castration-resistant prostate cancer: a multi-center experience from Turkey. International Journal of Contemporary Medical Research, 7(9), 112-116.,Doi: 10.21276/ijcmr.2020.7.9.30
• Terzioğlu K, Ayhan M. Distribution of allergens detected on patch tests of patients with allergic contact dermatitis and investigation of their atopic background. Annals of Medical Research, 29(5), 422-426., doi: 10.5455/annalsmedres.2021.07.490
• Arikan R, Atci MM, Ay S, Ayhan M, et all Prognostic significance of mucinous histology in left sided metastatic colorectal cancers with wild type RAS and evaluation of backbone chemotherapy regimens. Oncol Lett. 2023 Apr 5;25(5):208. doi: 10.3892/ol.2023.13795.
• Almuradova E, Yalcin S, Arıkan R, Ayhan M, Demir H, Cevik GT, Karaca M, Petekkaya I, Karabulut B. Survival of Patients With Metastatic Rectum Cancer Who Underwent Metastasectomy Following Conversion Chemotherapy Sans Pelvic Radiotherapy: A Turkish Oncology Group Study. Cureus 2023 May 17;15(5):e39119. doi: 10.7759/cureus.39119.
• Topcu A, Besiroglu M, Atci MM, Ayhan M, et all. Second-line Therapy after Trastuzumab Failure in HER2-Positive Metastatic Gastric Cancer: A Real-life Data. EJMI 2023;7(2):153–161. DOI: 10.14744/ejmi.2023.22720
• Book Writing:
• Drug interactions and side effects of targeted agents, Section name: (Small molecule tyrosine kinase inhibitors; ROS-1 targeted therapies (Crizotinib, Seritinib)) (2021)., AYHAN MURAT, Turkish Clinics Journal of Medical Sciences, Editor: Mehmet Aliustaoglu, Publishing number:1, Number of Pages 92, ISBN:978-625-401- 466-6, Turkish
• Approach to gastrointestinal stromal tumors and neuroendocrine tumors, Department name: (Medical approach in primary non-gastrointestinal neuroendocrine tumors) (2020)., AYHAN MURAT, Akademisyen Yayınevi, Editor: Anılır Ender, Number of editions: 1, Number of Pages 382, ISBN: 9786052585719, Turkish
• Internal medicine emergencies, Department name: (Oncological emergencies) (2022)., YILDIRIM SEDAT, AYHAN MURAT, Efe Academic Publishing, Editor: Serdar Olt, Number of editions: 1, Number of Pages 232, ISBN: 978-625-8324-66- 2, Turkish
• Physicians' chemotherapy cancer drug manual 2020, Section name: (Common chemotherapy regimens in clinical practice) (2022)., SÜMBÜL AHMET TANER, ALKAN ALI, AKSOY ASUDE, AYHAN MURAT, et all, Türkiye Klinikleri Journal of Medical Sciences, Editor: EDWAR CHU, VINCENT T. DEVITA, SAADDETIN KILIÇKAP, CEMIL BILIR, SELÇUK SEBER, Number of editions: 1, Number of pages 772, ISBN: 978-625-401-290- 7, Turkish (Book Translation)

Areas of Interests

• Surgical treatment of thyroid, parathyroid gland diseases and cancers
• Surgical treatment of adrenal gland (adrenal gland) diseases and cancers
• Laparoscopic & Robotic Surgery

Education:

• Galatasaray High School (1989-1997)
• Istanbul University, Istanbul Faculty of Medicine, Medical Education (1997-2003)
• Istanbul University, Istanbul Faculty of Medicine, Department of General Surgery, Specialization in General Surgery (2003-2009)
• Cleveland Clinic, Endocrine and Metabolism Institute, Center for Endocrine Surgery, USA, Research Fellowship (2014)
• Karolinska University Hospital, Department of Surgery, Division of Endocrine Surgery and Sarcoma Unit, Sweden, Endocrine Surgery Clinical Fellowship (2015)
• Ottawa University, Faculty of Medicine, Children's Hospital of Eastern Ontario, Apoptosis Research Center (ARC), Canada, Translational Medicine Clinical Research Fellowship (2016-2017)

Experience:

• LIV Hospital Ulus & LIV Hospital Vadistanbul
• Bakirkoy Dr. Sadi Konuk Training and Research Hospital (2012-2021)
• Ottawa University, Faculty of Medicine, Canada (2016)
• Karonlinska University Hospital, Sweden (2015)
• Cleveland Clinic, OH, USA. (2014)
• Iğdır State Hospital (2009-2012)

Memberships

• Endocrine Surgery Association, Member of the Board and Secretary General of the Association
• Dialogue Society in Endocrinology, Member
• Endoscopic Laparoscopic Surgery Association, Member
• Turkish Surgery Association, Member
• European Society of Endocrine Surgery(ESES), Member
• European Association for Endoscopic Surgery (EAES), Member
• Society of American Gastrointestinal and Endoscopic Surgeons (SAGES), Member
• Clinical Robotic Surgery Association (CRSA), Member
• American Association of Endocrine Surgeons (AAES), Member
• American College of Surgeons (ACS), Member

Medical Interests and Activities 

• Gastrointestinal diseases 

• Oncologic laparoscopic surgery 

• Anorectal area diseases 

• Urgent surgical cases (acute cholecystitis, divertikülit, ileus, pankreatit, appendicitis) 

• Colon and rectum cancer 

• Treatment of oncologic surgical cases with further laparoscopic and robotic surgery. • Laparoskopik hernia surgery 

• Esophagus and stomach cancer 

• Selim anorectal diseases (hemorrhoidal disease, anal fissure), perianal fistula, pilonoidal sinus (hairless- non-surgical treatment)

Education and Experience 

• İstanbul University Medical Faculty 1988 • University of Colorado Health Science Center – Intern Surgeon 

• Isparta, Dedeçam Şehit Ramazan Karaca Health Center (1995-1996) • İstanbul Surgery Hospital – American Hospital (2000-2001) 

• Chief assistant Istanbul Medical Faculty, Department of General Surgery (2001-2008) • World Congress on Peritonel Surface Malignancies (HIPEC course) Berlin, Germany (2012) 

• USC Keck School of Medicine, Los Angeles, CA, USA (2006-2007) 

• Assoc. Prof. M.D. , İstanbul Medical Faculty General Surgery (2008-2014) 

• Da Vinci Robotic Intensive Course at IRCAD, Strasbourg, France (2011) 

• Stony Brook Medicine Cadaver Training Event in Colon and Rectal Surgery, New York, USA (2016) (Instructor) 

• Fellow of the European Board of Surgery- Emergency Surgery (FEBS EmSurg) Honorary Diploma (2017) 

• Prof. M.D. , İstanbul Medical Faculty General Surgery (2014 -2017) 

• İstanbul University Medical Faculty – General Surgery Master of Science 1996 

• University of Southern California Medical Center, Department of General Surgery, Los Angeles, USA – February 2006 – February 2007

Scientific Publications • Endoscopic Laparoscopic & Minimal Invasive Surgery Journal Editorial Board / National Scientific Committee • UTACD Assist. Editor

Dr. Mustafa Emiroglu is a general surgery specialist at Memorial Bodrum Hospital. He has significant experience from his work at Sağlık Bilimleri University Tepecik SUAM (2016–2023) and Kırşehir Hospital (1997–1999).

He earned his medical degree from Istanbul University Cerrahpaşa Faculty of Medicine. He completed his specialization at Tepecik Training and Research Hospital. Dr. Emiroglu is a member of the Turkish Society of Surgery, the Endocrine Surgery Association, and the Colorectal Surgery Association.

He has attended advanced courses, including the Europe Senology Academia. He has also received training in proctologic, hemorrhoidal, and oncoplastic breast surgery, as well as thyroid diseases.

Dr Nimet Ozcan is a dermatologist with over 10 years of experience. She graduated from the Erciyes University Faculty of Medicine in 2008. She completed her dermatology specialization at Ankara Numune Training and Research Hospital in 2014. She provides care in both medical and cosmetic dermatology.

Clinical focus: acne, eczema, psoriasis, and fungal and bacterial infections. Dermato-oncology with early detection and surgical excision of suspicious lesions. Dermal fillers, chemical peels, and mesotherapy. Laser treatment for vascular lesions, pigmentation disorders, and hair removal. Pediatric dermatology. Languages: English.

Dermatologist Dr. Osman Serdar Akkaya graduated from Çukurova University Faculty of Medicine in 1981. He completed his dermatology specialization there in 1985. He has more than 35 years of experience and is among the most senior dermatologists in the region.

His practice includes general dermatology, such as psoriasis, eczema, acne, vitiligo, and urticaria. He focuses on dermato-oncology and performs surgery for benign and malignant skin tumors. He also offers cosmetic dermatology, including fillers, mesotherapy, and chemical peels. He provides laser and light-based treatments for vascular lesions, pigment disorders, scars, and hair removal. He treats geriatric skin conditions and chronic skin diseases.

Dr. Murat Erol is a general dentist with over 20 years of clinical experience. He graduated from Ege University Faculty of Dentistry in 2002. He provides care in English.

He offers preventive care and restorative treatments, including aesthetic fillings, crowns, and bridges. He also performs root canal therapy. His aesthetic services include whitening, composite bonding, and smile design. He provides fixed and removable prosthetics. His plans focus on oral function and natural aesthetics. Each treatment is tailored to the patient.

Dyt. Yaren Nur Güngör is a dietitian. She graduated from the Faculty of Nutrition and Dietetics. She provides evidence-based, personalized nutrition counseling in English. She designs tailored programs for health promotion, disease management, and weight control.

Her clinical focus includes diet plans for diabetes, heart disease, thyroid disorders, and other metabolic issues. She also guides weight loss and gain and improves body composition. She offers sports nutrition and nutrition care for children and teens. She provides preventive nutrition with lifestyle counseling. Her approach is patient-centered and motivating.

Dr. Ozlem Yogurtcu is a general surgeon with extensive experience. She graduated from Dokuz Eylul University Faculty of Medicine. She completed her general surgery residency at Haseki Training and Research Hospital, 1st Surgical Clinic. She is fluent in English.

Her practice includes gastrointestinal surgery (gallbladder disease, hernias, appendicitis, other gastrointestinal conditions). It also includes endocrine surgery (thyroid, parathyroid, adrenal) and breast surgery (benign and malignant conditions). She treats emergency and trauma cases. She performs minimally invasive laparoscopic procedures.

She is known for precise surgery and a patient-centered approach.

Dr Erdem Gelegen is an ophthalmologist with over 20 years of experience in cataract, refractive, retinal, glaucoma, and corneal/anterior segment care. He performs phacoemulsification with premium intraocular lenses. He provides laser vision correction for myopia, hyperopia, and astigmatism. He treats diabetic retinopathy, age-related macular degeneration, retinal detachment, keratoconus, and anterior segment disorders, including corneal transplants.

He graduated from Istanbul University Cerrahpaşa Faculty of Medicine in 1999. He completed his ophthalmology residency at Okmeydanı Training and Research Hospital in 2004. He is known for precise microsurgery and the use of advanced ophthalmic technologies.

Dr. Cevat Azeroglu is a radiologist. He graduated from the Tabriz University Faculty of Medicine in 1987. He completed his radiology specialization at Ondokuz Mayıs University in 2011. Born in 1959, he provides advanced imaging to support accurate, timely decisions for many specialties.

His expertise includes conventional radiology with X-rays for musculoskeletal and chest disease. He performs ultrasound of the abdomen, thyroid, vessels, and soft tissues. He interprets CT and MRI for neurological, cardiovascular, and oncologic conditions. He practices interventional radiology with image-guided, minimally invasive procedures. He also focuses on oncologic imaging for staging and follow-up. He is known for diagnostic precision, use of modern imaging tools, and strong teamwork.

Dr. Sema Karakas specializes in gynecologic oncology surgery. She also performs minimally invasive gynecologic surgery, including laparoscopy and V-NOTES (scarless) techniques.

She offers V-NOTES hysterectomy and cyst removal. She performs surgery for uterine cancer and tubal ligation. She provides a full range of laparoscopic gynecologic procedures. She treats urinary incontinence with medical, laser, or surgical options and pelvic floor physiotherapy. She manages HPV with diagnosis, treatment, and follow-up. She performs colposcopy, LEEP, and conization. She provides endometriosis care and surgery. She treats polyps and uterine septum with hysteroscopy. She offers perimenopausal and menopausal care and bioidentical hormone therapy.

Assoc. Prof. Dr. Saydam Mehmet is a general surgeon at Lokman Hekim Istanbul Hospital (2025–present). His work covers oncologic, endocrine, and metabolic surgery. He performs laparoscopic surgery, including hernia repair and anti-reflux procedures. He also treats morbid obesity and type 2 diabetes. Sleeve gastrectomy is among his key procedures.

Education: He graduated from the Gülhane Military Medical Academy, Faculty of Medicine (1995–2001). He completed his general surgery residency there (2004–2009). He was a research fellow at the University of Miami/Jackson Memorial Hospital, Ryder Trauma Center (2015–2016).

Experience: He worked as a general surgery specialist at GATA Haydarpaşa, Girne Military, and Mevki Military. He later served as Associate Professor of General Surgery at Dışkapı, Sancaktepe, and Medical Park Gebze. Earlier, he practiced as a general practitioner in military medical services.